Search results
You’ve covered your copayment; now brace yourself for the ‘facility fee’
Maine Morning Star via Yahoo News· 2 hours agoEven if you have health insurance, you might expect to be charged a copayment for some routine care,...
DEA’s Psychedelic-Outlawing Effort Attacked by Private Industry | The Legal Intelligencer
Law.com· 8 hours agoDespite the U.S. Food and Drug Administration’s (FDA) approval of depression treatment drug...
Biden’s Climate Emergency: Green Policies On Steroids?
Forbes· 21 hours agoAccording to a Bloomberg report last week, White House officials have renewed discussions about...
Mass. Sen. Warren, Dems, want DEA to bump cannabis from most dangerous drugs list
The Republican· 3 days agoIt might be perfectly legal for adult Bay State residents to purchase recreational cannabis from...
AP Trending SummaryBrief at 4:31 p.m. EDT
Traverse City Record-Eagle· 2 days agoSean “Diddy” Combs has pushed back against a woman’s lawsuit that accused him of sexual assault. Combs’ lawyers filed a motion Friday to dismiss some claims that were not under law when the ...
Lawmakers urge DEA to pick up the pace on marijuana scheduling review
Courthouse News Service· 4 days agoMembers of Congress on Wednesday once again pushed the U.S. Drug Enforcement Administration to...
Opinion | RFK Jr.'s surprising pivot on climate change should have Trump worried
MSNBC via Yahoo News· 5 days agoKennedy also has changed his tune on fracking, a drilling method for extracting natural gas or oil...
Is India an Autocracy?
The Atlantic· 3 days agoThe assault on expression, and on virtually every other mainstay of democracy, has become commonplace under Prime Minister Narendra Modi’s government,...
Mastercard: How To Spark a Revolution in Inclusion
Morningstar· 3 days agoSmart people and smart ideas are a dime a dozen, U.S. Commerce Secretary Gina Raimondo told an audience of, well, smart people with smart ideas in Washington ...
AMGEN TO SUBMIT TEPROTUMUMAB MARKETING AUTHORIZATION APPLICATION TO THE EUROPEAN MEDICINES AGENCY
Morningstar· 3 days agoAmgen (NASDAQ:AMGN) today announced the imminent submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for teprotumumab, a fully human monoclonal antibody ...
